Rymarz Zdort advises HigoSense on EUR 5 million Series A funding round

10 January 2022

Rymarz Zdort advised HigoSense sp. z o.o. (“HigoSense”), a Warsaw-based digital healthcare provider, and its founders in connection with a EUR 5 million Series A funding round led by Cogito Capital Partners, with the participation of existing early-stage investors.

HigoSense, is a health-tech start-up established in 2017 offering a mobile medical examination device that is supported by a mobile app and an online AI-powered health diagnostic platform. HigoSense enables doctors to perform high-quality remote patient examinations and patients to perform examinations, as well as collect diagnostic data prior to or during a telehealth session.

Cogito Capital Partners focuses on providing support in management, financing and market expansion to technology companies with high-growth potential and helping them expand internationally.

The team advising on the transaction comprised Paweł Zdort, a managing partner, supported by Monika Michałowska, an associate. Robert Krasnodębski, a partner, was responsible for the tax aspects of the transaction.

Team members

Paweł Zdort

Managing Partner

Paweł Zdort

Robert Krasnodębski

Partner

Robert Krasnodębski

Monika Michałowska

Associate

Monika Michałowska

More news

SIGN IN
to our
Newsletter

Confirm your email

Check your mailbox and click the link to confirm your subscription to our Newsletter.

Thank you!